Synthesis and antiproliferative activity of N-acylaspartic acid dimethyl esters

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 2117-2120

  Schlitzer, Martin ^a   Sattler, Isabel ^b   Dahse, Hans Martin ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b HANS KNÖLL INSTITUTE   (Germany)

Author keywords

Antiproliferative activity; Aspartates

Indexed keywords

ALIPHATIC CARBOXYLIC ACID; AROMATIC CARBOXYLIC ACID; ASPARTIC ACID DERIVATIVE; ESTER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN HL 60; CELL STRAIN K 562; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ACYLATION; ALKYL AND ARYL TRANSFERASES; ANTINEOPLASTIC AGENTS; ASPARTIC ACID; CELL DIVISION; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; ESTERS; FARNESYLTRANSTRANSFERASE; GROWTH INHIBITORS; MOLECULAR STRUCTURE; NEOPLASM PROTEINS; POLYISOPRENYL PHOSPHATES; PROTEIN ISOPRENYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0032806605     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Clarke S: Protein isoprenylation and methylation at carboxy- terminal cysteine residues. Annu Rev Biochem 61: 355-86, 1994.
2. Casey PJ: Protein lipidation in cell signaling. Science 268: 221-225, 1995.
3. Heimbrook DC, Oliff A: Therapeutic intervention and signaling. Curr Opin Cell Biol 10: 284-288, 1998.
4. Leonhard DM: Ras farnesyltransferase: a new therapeutic target. J Med Chem 40: 2971-2990, 1997.
5. Ma YT, Gilbert BA, Rando RR: Inhibitors of isoprenylated protein endoprotease. Biochem 32: 2386-2393, 1993.
6. Jang GF, Gelb MH: Substrate specificity of mammalian prenyl protein-specific endoprotease activity. Biochem 37: 4473-4481, 1998.
7. Gilbert BA, Tan EW, Perez-Sala D, Rando RR: Structure- activity studies on the retinal rod outer segment isoprenylated protein methyltransferase. J Am Chem Soc 114: 3966-3973, 1992.
8. Gilbert, BA, Lim Y-H, Ding J, Badwey JA, Rando RR: Farnesyl thiotriazole, a potent neutrophil agonist and structurally novel activator of protein kinase C. Biochem 34: 3916-3920, 1995.
9. Haklai R, Weisz MG, Elad G, Paz A, Marciano D, Egozi Y, BenBaruch G, Kloog Y: Dislodgement and accelerated degradation of ras. Biochem 37: 1306-1314, 1998.
10. Perez-Sala D, Gilbert BA, Rando RR, Canada FJ: Analogs of farnesylcysteine induce apoptosis in HL-60 cells. FEBS Lett 426: 319-324, 1998.
11. Schlitzer M, Sattler I: Carboxylic acids as farnesyl surrogates in farnesyldiphosphate based farnesyltransferase inhibitors. In review.
12. Patel DV, Schmidt RJ, Biller SA, Gordon EM, Robinson SS, Manne V: Farnesyl diphosphate-based inhibitors of ras farnesyl protein transferase. J Med Chem 38: 2906-2921, 1995.
13. Baker B, Neeman JP: Irreversible enzyme inhibitors. 195. Inhibitors of thymidine kinase from walker 256 carcinoma derived from thymidine 5'-acetate. J Med Chem 15: 940-944, 1972.
14. Marshall CJ: Protein prenylation: a mediator of protein- protein interactions. Science 259: 1865-1866, 1993.
15. Zhang FL, Casey PJ: Protein prenylation: molecular mechanism and functional consequences. Annu Rev Biochem 65: 241-269, 1996.
16. Porfiri E, Evans T, Chardin P, Hancock JF: Prenylation of ras is required for efficient hSOSl-promoted guanine nucleotide exchange. J Biol Chem 269: 22672-22677, 1994.
17. Kuruda Y, Suzuki N, Kataoka T: The effect of posttranslational modifications on the interaction of ras2 with adenylyl cyclase. Science 259: 683-686, 1993.
18. Iniguez-Lluhi JA, Simon MI, Robishaw JD, Oilman AG: G protein Bγ subunits synthesized in Sf9 cells. J Biol Chem 267: 23409-23417, 1992.
19. Fukada Y, Takao T, Ohguro H, Yoshizawa T, Akino T, Shimonishi Y: Farnesylated γ-subunit of photoreceptor G protein indispensable for GTP-binding. Nature 346: 658-660, 1990.
20. Gosser YQ, Nomanbhoy TK, Aghazadeh B, Manor D, Combs C, Cerione RA, Rosen MK: C-terminal binding domain of RhoGDP-dissociation inhibitor directs N-terminal inhibitory peptide to GTPases. Nature 387: 814-819, 1997.
21. Chuang T-H, Bohl BP, Bokoch GM: Biologically active Llipids are regulators of RacGDI complexation. J Biol Chem 268: 26206-26211, 1993.
22. Scheer A, Gierschik P: S-prenylated cysteine analogues inhibit receptor-mediated G protein activation in native human granulocyte and reconstituted bovine retinal rod outer segment membranes. Biochemistry 34: 4952-4961, 1995.
23. Shirataki H, Kaibuchi K, Isomura M, Araki S, Sasaki T, Takai Y: Inhibition fo the action of stimulatory GDP/GTP exchange protein for smg p21 by the geranygeranylated synthetic peptides designed from its C-terminal region. J Biol Chem 266: 20672-20677, 1991.